News
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the ...
A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...
Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. This was in early pandemic ...
Australia ‘undervalues’ the products of drug companies, Pfizer has told the Productivity Commission, echoing US lobbyists ...
Zohran Mamdani told a group of top business leaders in New York City on Tuesday that he would discourage the use of the ...
Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...
Explore more
President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Trump pharma and chip tariffs may start this month, sparking price hikes, inflation, and global trade ripples.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results